Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 2)
13 August 2026
LKAB Q2 2026: Earnings hit by USD hedging and higher costs
Stable production and deliveries but lower sales and operating profit due to USD hedging losses and higher energy, maintenance and urban transformation costs; two key permits granted.
12 August 2026
thyssenkrupp nucera doubles nine‑month order intake, halts SOEC mass‑production plan
Nearly doubled nine‑month order intake; wins Moeve 300‑MW contract with service package; discontinues SOEC mass‑production, incurring ~€30m one‑time EBIT hit and updating FY26 outlook.
12 August 2026
Bilfinger Q2 2026 financial results
Revenue rose 7% to €1,450m while orders fell 16% to €1,498m; EBITA margin 5.3%. Outlook confirmed: revenue €5.4–€5.9bn, FCF €250–€300m (includes Teknokon).
12 August 2026
Brenntag Q2 2026 results — sales €4.3bn; guidance raised
Sales up 11% to €4.3bn; operating EBITDA +41% to €463m; gross margin rose to 26.9%. Guidance increased to €1,350–1,450m for 2026.
12 August 2026
SOCAR 2025 Sustainability Report
First Double Materiality Assessment, new ESG Data Platform and Decarbonization Roadmap; ~1 million tCO₂e avoided, USD 200m Green Bonds and local procurement at 88%.
10 August 2026
PTT Global Chemical (GC) starts new growth chapter — petrochemicals, specialty & Green‑Bio, Map Ta Phut
Q2 adjusted EBITDA THB 26.932bn; ethane imports from the US due 2029; portfolio shift to 70:30 specialty by 2030; USD 300m EBITDA uplift target by 2030.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
10 August 2026
PTT Global Chemical strengthens petrochemicals, accelerates Specialty and Green & Bio; positions Map Ta Phut as APAC growth base
Reinforces integrated petrochemical core, starts ethane imports in 2029, shifts toward higher‑value Specialty and Green & Bio, and expands Map Ta Phut as a regional hub.
7 August 2026
Fluor Corporation second-quarter 2026 results
Revenue rose 9% to $4.3B; new awards $6.1B and backlog $26.9B; adjusted EBITDA guidance narrowed and reduced; $300M returned to shareholders in Q2.
7 August 2026
LOTTE Chemical Q2 2026 results and restructuring push
Posted KRW 5.6864 trillion revenue and KRW 110.1 billion operating profit; advancing Daesan and Yeosu restructurings and bringing Yulchon compounding plant into operation this year.
7 August 2026
MOL Group Q2 2026 results
Q2 profit USD 786m; strong oil and gas prices plus higher refining and petrochemical margins offset fuel price caps and operational outages.
7 August 2026
LANXESS posts higher Q2 2026 sales and EBITDA pre exceptionals
Sales up 6.5% to EUR 1.561bn; EBITDA pre exceptionals EUR 152m; QoQ earnings jump 61.7%; full-year EBITDA guidance EUR 450–550m confirmed.
7 August 2026
FY2026 1Q consolidated results
Q1 sales and profits rose on higher methanol and polycarbonate prices, inventory gains and yen weakness; full-year guidance lifted and dividend increased, but methanol-price risk remains.
6 August 2026
Trinseo Q2 2026 financial results
Net loss $120M; adjusted EBITDA $81M; free cash flow negative $125M; advancing DIP-backed debt restructuring and restarted Americas Styrenics sale.
6 August 2026
PureCycle Technologies Q2 2026 results and commercial ramp
Revenue $4.5M; first P&G resin deliveries; PureFive approved as post‑consumer recycled content in New Jersey; Ironton compounding online; liquidity $236.9M.
6 August 2026
Petrobras posts R$52.4bn Q2 2026 profit
Quarterly results bolstered by record own oil output, above-100% refinery utilization and higher derivative production, supporting cash generation and lower imports.
6 August 2026
ORLEN Group posts record Q2 2026 profits and PLN 14.7bn H1 capex
Q2 results: revenue PLN 76.5bn, LIFO EBITDA PLN 13.9bn, net profit PLN 7.7bn; record foreign retail profits and H1 capital expenditure PLN 14.7bn.
6 August 2026
Aurubis raises full‑year outlook after stronger Q3 and major project progress
Group EBT and ROCE improved; Q3 outperformed prior quarters; large recycling plant started and ~90% of €1.7bn investment programme completed.
5 August 2026
Albemarle Q2 2026 results
Net sales $1.7bn; adj. EBITDA $858m; Energy Storage driving results; capex trimmed to ~$500m; expected 225–235 kt LCE sales volume range after Talison CGP3 fire.
5 August 2026
SEQENS agrees in principle to comprehensive financial restructuring
Agreement in principle with creditors to deleverage the balance sheet, convert senior lenders into shareholders and preserve operations; completion expected by end of 2026.
5 August 2026
Eli Lilly Q2 2026 results: revenue +48%, raises guidance; retatrutide package complete
Revenue rose 48% to $23.0bn driven by Mounjaro and Zepbound; updated 2026 revenue guidance to $85–87bn; retatrutide Phase 3 package complete supporting a Q1 2027 BLA.
4 August 2026
Celanese Q2 2026 earnings and results
Adjusted EPS $2.45; net sales $2.8bn; adjusted EBIT $470m and operating EBITDA $649m. Q3 EPS guide $1.35–$1.75; full-year adjusted EPS ~$6.00 and FCF $700–$800m.
4 August 2026
SABIC completes sale of Engineering Thermoplastics business in Americas and Europe to Mutares
Sale of ETP assets for $450 million improves EBITDA margin ~130–140 bps and removes a loss-making unit from the portfolio.
4 August 2026
Aramco Q2 and H1 2026 results
Strong H1 profits and cash flow; Q2 free cash flow hit by $13.6bn working-capital build. Dividend declared and key upstream/gas projects on track for 2026–27 completion.
3 August 2026
bp sells Gelsenkirchen refinery to Klesch Group
Sale reduces underlying opex by about $1 billion, is free-cash-flow accretive based on historical performance, and transfers assets, liabilities and employees.
31 July 2026
LG Chem Q2: KRW 14.1759tn revenue and KRW 599.6bn operating profit
Revenue rose 19% YoY and operating profit 25.8% YoY; petrochemical spreads and battery-materials demand lifted results, while Q3 shows mixed outlook across divisions.
31 July 2026
Novo Nordisk: ZEUS phase 3 finds no MACE reduction with ziltivekimab
Ziltivekimab lowered free IL‑6 and hsCRP but did not reduce cardiovascular events; safety similar to placebo except for more serious infections; related trials continue with H1 2027 readouts.
31 July 2026
LyondellBasell Q2 2026 earnings
EBITDA $1.3bn ($2.1bn ex-items); net income $0.6bn ($1.4bn ex-items); completed European asset divestiture; $500m Cash Improvement Plan target by end‑2026.
31 July 2026
Moeve H1 2026: €1.2bn Clean CCS EBITDA; 69% of H1 capex to energy transition in Spain
Net income €458m, capex €605m and operating cash flow €762m; leverage fell to 1.2x; groundbreaking for 300 MW Andalusian Green Hydrogen Valley on Sept 17; Galp merger talks continue.
31 July 2026
FUCHS JV ALHAMRANI FUCHS PETROLEUM Yanbu plant severely damaged by fire
Fire on July 25 damaged production and filling units in Yanbu; operations suspended, no injuries. Customer supply to be maintained via alternative production and sourcing while reconstruction is planned.
31 July 2026
bp launches sale process for its North Sea business
Launching a process to market its North Sea business for potential sale, part of a portfolio review to focus capital on highest-value opportunities.
← Previous
Next →
